PD-L1 expression in tumor tissue correlates with the response to ICIs in different solid tumors, including Non-Small-Cell Lung Cancer (NSCLC) [8], and endometrial [13], triple-negative breast [14], head and neck tumors [15]. This evidence concerns the gene CD274 and neoplasm.